17 related articles for article (PubMed ID: 38493839)
1. UV imaging for the rapid at-line content determination of different colourless APIs in their tablets with artificial neural networks.
Ficzere M; Alexandra Mészáros L; Diószegi A; Bánrévi Z; Farkas A; Lenk S; László Galata D; Kristóf Nagy Z
Int J Pharm; 2024 May; 657():124174. PubMed ID: 38701905
[TBL] [Abstract][Full Text] [Related]
2. The Role of Particle Surface Area and Adhesion Force in the Sticking Behavior of Pharmaceutical Powders.
Capece M
J Pharm Sci; 2019 Dec; 108(12):3803-3813. PubMed ID: 31473214
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Occurrence of Sticking during Tablet Production by Shear Testing of a Pharmaceutical Powder.
Nakamura S; Otsuka N; Yoshino Y; Sakamoto T; Yuasa H
Chem Pharm Bull (Tokyo); 2016; 64(5):512-6. PubMed ID: 27150485
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
5. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
Huang Z; Scicolone JV; Han X; Davé RN
Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
[TBL] [Abstract][Full Text] [Related]
6. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
[TBL] [Abstract][Full Text] [Related]
7. UV-VIS imaging-based investigation of API concentration fluctuation caused by the sticking behaviour of pharmaceutical powder blends.
Péterfi O; Mészáros LA; Szabó-Szőcs B; Ficzere M; Sipos E; Farkas A; Galata DL; Nagy ZK
Int J Pharm; 2024 Apr; 655():124010. PubMed ID: 38493839
[TBL] [Abstract][Full Text] [Related]
8. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract].
Zgoda MM; Nachajski MJ; Kołodziejczyk MK
Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
